Condition: Amyotrophic Lateral Sclerosis · Sponsor: Swathy Chandrashekhar, MBBS
The purpose of this study is to evaluate safety, effect on cramps, function and quality of life of ranolazine versus placebo for the treatment of ALS.
This description comes directly from the study's public registry record.
Katie Lillig, BS · 913-945-9932 · Kjennens2@kumc.edu
Always discuss trial participation with your own doctor first.
| University of California, San Francisco | San Francisco, California, United States | Recruiting |
| Mayo Clinic Florida | Jacksonville, Florida, United States | Recruiting |
| University of Kansas Medical Center | Fairway, Kansas, United States | Recruiting |
| University of Kansas Medical Center: Wichita | Wichita, Kansas, United States | Recruiting |
| University of Missouri Health Care | Columbia, Missouri, United States | Recruiting |
| The Ohio State University | Columbus, Ohio, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06527222